Abstract
Nociceptive pain is a type of pain: pain that arises from actual or threatened damage to non-neural tissue through the activation of nociceptors, the sensory receptors that detect noxious stimuli. It is one of three mechanistic descriptors in the modern taxonomy of pain, set against neuropathic pain, which follows a lesion of the somatosensory nervous system, and nociplastic pain, which arises from altered nociception without tissue damage or nerve lesion. Cognitive psychology treats even this physiological category of pain not as a passive readout of receptor firing but as a constructed perception, shaped between nociceptor and felt experience by attention, expectation, and emotion. This article develops that view through the biology of nociceptors, the mechanistic taxonomy that gives nociceptive pain its meaning, its somatic and visceral forms, and the cognition that determines how much a noxious input hurts.
Keywords: nociceptive pain, nociception, nociceptor, mechanistic taxonomy, pain perception
Nociceptive pain is the kind of pain most people mean by the word: the sting of a burn, the ache of a bruise, the sharp report of a stubbed toe. It is the pain of a working alarm system, generated when specialized receptors detect that tissue is being damaged and signal that fact to the brain. Precisely because it is the default case, it is the reference point against which the other kinds of pain are defined, and defining it carefully turns out to matter clinically: a pain driven by ongoing tissue injury calls for a different response than one driven by a damaged nerve or by a nervous system that has learned to hurt on its own. The International Association for the Study of Pain fixes the anchor by defining pain itself as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage, deliberately separating the experience from the injury that usually provokes it (Raja et al., 2020). Nociceptive pain is the branch of that definition where the tissue-damage link is real and mechanistically legible, and even here the experience is never a fixed function of the injury.
- Nociceptive pain is pain that arises from actual or threatened damage to non-neural tissue through the activation of nociceptors, distinguishing it from neuropathic pain (from a nerve lesion) and nociplastic pain (from altered nociception without tissue damage).
- Nociceptors are specialized primary afferent neurons whose molecular receptors transduce noxious thermal, mechanical, and chemical stimuli into electrical signals; their discovery earned the 2021 Nobel Prize in Physiology or Medicine.
- The mechanistic taxonomy of nociceptive, neuropathic, and nociplastic pain, formalized for ICD-11, classifies pain by its underlying mechanism rather than its location or duration, because mechanism guides treatment.
- Nociceptive pain divides into somatic pain, which is well localized and sharp, and visceral pain, which is diffuse, poorly localized, and often referred to distant body-wall sites.
- Nociception is not the same as pain: the felt experience is constructed by the brain from nociceptive input together with attention, expectation, and emotion, so even nociceptive pain is modulable rather than fixed.
What Nociceptive Pain Is
Nociceptive pain is defined by its mechanism, not by its severity, location, or time course. It is the pain that results when nociceptors, the sensory receptors specialized for noxious stimuli, are activated by actual or threatened damage to non-neural tissue, and it is the term reserved for a normally functioning somatosensory system responding to injury as it evolved to do (Loeser & Treede, 2008). This is what sets it apart from the other mechanistic categories. In neuropathic pain the lesion is in the somatosensory nervous system itself, so the alarm is generated by damage to the wiring rather than by the tissue the wiring monitors. In nociplastic pain there is neither evident tissue damage activating nociceptors nor a lesion of the somatosensory system, yet pain arises from altered nociceptive processing — a nervous system that hurts without the peripheral cause the other two categories require.
The distinction is not academic. The Kyoto revision of IASP pain terminology defined nociceptive pain precisely as pain arising from the activation of nociceptors, in explicit contrast to neuropathic pain, in order to keep the mechanism of a pain separate from its cause, its location, and the disease behind it (Loeser & Treede, 2008). A cancer that erodes bone, a joint worn by osteoarthritis, and a surgical incision are different diseases with different courses, but each hurts by the same route — the activation of nociceptors in intact, non-neural tissue — and so each produces nociceptive pain. Naming the mechanism rather than the disease is what lets the taxonomy generalize across the enormous range of conditions that hurt.
The conceptual foundation beneath all of this is the distinction between nociception and pain. Nociception is the neural process by which noxious stimuli are detected, transduced into electrical signals, and transmitted toward the spinal cord and brain; pain is the conscious, felt experience the brain constructs. The two ordinarily travel together in nociceptive pain, which is exactly why the category is the clearest case for studying them, but they remain distinct: nociception can occur without pain, as in the wounded who feel nothing in the moment of injury, and pain can occur without nociception, as the other mechanistic categories show. Holding the two apart is the move that lets psychology into a mechanism that looks, at first, purely physiological.
Types of Nociceptive Pain
In the MeSH classification nociceptive pain is filed directly under the broader heading of pain, and it carries a single narrower descriptor beneath it. Listing that subtype is a matter of how the literature is indexed, not a claim that nociceptive pain divides cleanly at one joint: MeSH is an indexing vocabulary, the subtype below is not mutually exclusive with the somatic-versus-visceral division described in the same breath, and a given pain can be labeled several ways at once. With that caveat, the direct MeSH subtype is the following.
| Subtype | In brief |
|---|---|
| Visceral Pain | Nociceptive pain originating in the internal organs. Because visceral afferents are sparse and converge with somatic ones in the spinal cord, it is diffuse, hard to localize, and frequently referred to a patch of body wall sharing the same spinal segment — the appendix first felt near the navel, the heart in the left arm. It contrasts with somatic nociceptive pain, which the dense receptors of skin and musculoskeletal tissue localize sharply. |
The more useful division for understanding nociceptive pain is the one MeSH does not tabulate: between somatic and visceral pain. Somatic nociceptive pain arises in the skin, muscles, joints, and bones, tissues densely supplied with nociceptors and mapped precisely onto the somatosensory cortex, so it is typically sharp, well localized, and easy to point to. Visceral nociceptive pain arises in the internal organs, tissues sparsely supplied with afferents that are tuned to distension and ischemia rather than cutting, and whose signals converge with somatic input in the dorsal horn — so it is dull, diffuse, hard to localize, and characteristically referred to a distant somatic site. The two share a mechanism, the activation of nociceptors in non-neural tissue, but differ in everything the mechanism produces at the level of experience, which is why the somatic-visceral axis carries more explanatory weight than the single MeSH subtype.
Nociceptors and the Transduction of Injury
The peripheral event in every nociceptive pain is the same: a nociceptor detects that tissue is being harmed and converts that fact into a train of electrical impulses. Nociceptors are the primary afferent sensory neurons specialized for this job, with cell bodies in the dorsal root and trigeminal ganglia and free nerve endings in the tissue they monitor (Basbaum et al., 2009). What makes them nociceptors is not the anatomy of the ending but the molecular receptors it carries. The molecular era of pain science began with the identification of the receptors that transduce noxious stimuli — the capsaicin- and heat-gated ion channel TRPV1 foremost among them — which showed that the specificity older theories had only posited was real and molecular: distinct channels detect noxious heat, noxious cold, intense mechanical force, and the chemical signatures of inflammation (Julius & Basbaum, 2001).
Most nociceptors are polymodal, carrying several such channels and so responding to more than one kind of noxious stimulus, which is why an injury that is simultaneously hot, crushing, and inflamed recruits a single population of fibers (Dubin & Patapoutian, 2010). The signal they generate travels centrally over two fiber classes whose conduction speeds produce the familiar double structure of acute injury pain: fast, thinly myelinated Aδ fibers carry the sharp, immediate first pain that localizes the injury, while slow, unmyelinated C fibers carry the dull, aching second pain that follows and lingers (Yam et al., 2018). The whole peripheral apparatus — the receptor channels, the polymodal endings, the two-speed transmission — is the machinery that turns a physical insult into the input the rest of the system works on. The first demonstration puts a single polymodal nociceptor on screen, letting the stimulus modality and intensity be set to show when the receptor crosses threshold and how hard it then fires.
Demo 1 — A nociceptor transduces injury
Firing rate = max(0, 10 × (8 − 4)) = 40 impulses/s. A genuinely noxious stimulus drives strong firing that is transmitted centrally as the input for pain.
A polymodal nociceptor carries several receptor channels, so it responds to heat, pressure, and inflammatory chemicals alike. Inflammation lowers its threshold and raises its gain (peripheral sensitization), which is why the same touch that was silent in healthy tissue can hurt in injured tissue. Threshold-linear model for illustration, not calibrated firing rates.
Transduction is also the first point at which the peripheral signal is not fixed. Injured and inflamed tissue releases a chemical soup — protons, bradykinin, prostaglandins, cytokines, nerve growth factor — that sensitizes the nociceptor, lowering its threshold and raising its gain so that stimuli which were innocuous now hurt and stimuli which already hurt hurt more (Basbaum et al., 2009). This peripheral sensitization is why a sunburned shoulder screams at a warm shower: the tissue is not more damaged by the water, but its nociceptors have been retuned. It is the peripheral half of a plasticity whose central half — the amplification of the signal once it reaches the cord — is what most complicates nociceptive pain over time.
The Mechanistic Taxonomy of Pain
Nociceptive pain acquires its meaning only within the taxonomy that opposes it to the other mechanisms by which pain is generated. That taxonomy has three terms. Nociceptive pain arises from the activation of nociceptors by damage to non-neural tissue. Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system itself — a severed nerve, a diabetic neuropathy, a stroke affecting the sensory pathways — so that the alarm is generated by damage to the signaling apparatus rather than to the tissue it reports on. Nociplastic pain arises from altered nociception despite no clear evidence of tissue damage activating nociceptors and no lesion of the somatosensory system, and it names the mechanism behind conditions such as fibromyalgia in which pain is real but the peripheral cause the first two categories require is absent (Treede et al., 2019).
The taxonomy was not a philosopher's tidy scheme but a clinical necessity, formalized in the IASP Classification of Chronic Pain adopted for the World Health Organization's ICD-11 (Treede et al., 2019). Its logic is that mechanism, not location or duration, is what should guide treatment: an anti-inflammatory that quiets sensitized nociceptors is the right tool for a nociceptive pain and the wrong one for a neuropathic pain that needs a drug acting on aberrant neural signaling. The categories are descriptors of mechanism rather than mutually exclusive diagnoses, and a single patient can carry more than one — a cancer producing nociceptive pain from bone erosion and neuropathic pain from a tumor pressing on a nerve — which is why the modern framing speaks of the predominant mechanism rather than a single label (Woolf, 2010). The second demonstration makes this classification explicit, letting the presence of tissue damage, a nerve lesion, and central amplification be toggled to see which mechanism the combination implies. Table 2 sets the three categories side by side, and Figure 1 places them on the axes that separate them.
Demo 2 — Classify the pain mechanism
Mechanism: Nociceptive pain. Because nociceptors are activated by damage to intact non-neural tissue, the defining case of nociceptive pain.
The categories are read in order of the questions clinicians actually ask: is the nervous system itself lesioned (neuropathic)? If not, is nociceptor-activating tissue damage present (nociceptive)? If neither, is there altered central nociception (nociplastic)? The descriptors are not exclusive — a single patient can carry more than one, and a persistent nociceptive pain can acquire central amplification (Treede et al., 2019).
Figure 1
The Three Mechanistic Categories of Pain
| Category | Underlying mechanism | Representative conditions |
|---|---|---|
| Nociceptive | Activation of nociceptors by actual or threatened damage to non-neural tissue; the somatosensory system is intact. | Osteoarthritis, burns, fractures, surgical and inflammatory pain. |
| Neuropathic | A lesion or disease of the somatosensory nervous system itself generates the pain signal. | Diabetic neuropathy, post-herpetic neuralgia, nerve injury, central post-stroke pain. |
| Nociplastic | Altered nociception with no evident tissue damage activating nociceptors and no somatosensory lesion. | Fibromyalgia, some chronic low back pain, irritable bowel syndrome. |
From Nociception to Felt Pain
Having a working nociceptor is necessary for nociceptive pain but not sufficient for it, because between the receptor and the felt experience sits the whole modulating machinery of the central nervous system. The single most consequential idea about that machinery is gate control theory, proposed by Ronald Melzack and Patrick Wall in 1965. Before it, pain was explained by specificity theory, on which a dedicated line carried a pain signal from receptor to a pain center with intensity a simple function of stimulus strength — a picture that could not accommodate the everyday facts that rubbing an injury relieves it, that mood and attention change how much things hurt, and that wounds can be painless in the moment. Melzack and Wall proposed instead that transmission of nociceptive signals from the spinal cord to the brain is regulated by a neural gate in the dorsal horn, whose opening and closing is set by the balance of activity in large- and small-diameter afferents and, crucially, by descending influences from the brain (Melzack & Wall, 1965).
The gate gave psychology a foothold in the nervous system. Large-diameter fibers carrying touch tend to close the gate, which is why rubbing a banged shin helps; small-diameter nociceptive fibers tend to open it; and a descending system carrying attention, expectation, and emotion can itself open or close it, so a psychological state becomes a signal converging on a specific spinal circuit rather than a vague influence (Melzack & Wall, 1965). Melzack later folded this into a broader claim that the brain generates the felt body and its pains from a widely distributed network he called the neuromatrix, shaped by but not dictated by sensory input — a view that explains how pain can be experienced even when the input is absent (Melzack, 1999). The nociceptive signal, in short, is amplified or dampened at every synapse on its way up, and what the brain finally constructs is not the injury but a modulated version of the report about it. The third demonstration lets somatic and visceral nociceptive input be compared directly, showing how the density of afferents and their convergence in the cord set how precisely a pain can be localized and why visceral pain is referred.
Demo 3 — Why visceral pain is diffuse and referred
Localization error ≈ 4.0 cm (moderate). Low convergence and dense innervation let the pain be localized sharply and correctly, the signature of somatic nociceptive pain.
Somatic tissue is densely innervated and its afferents map cleanly onto the cortex, so somatic pain is sharp and well localized. Visceral tissue is sparsely innervated and its afferents converge with somatic ones on shared dorsal-horn neurons, so visceral pain is diffuse and referred to the body wall. Same mechanism — nociceptor activation — but very different experience. Illustrative model, not calibrated distances.
The plasticity does not stop at the gate. Sustained nociceptive input drives central sensitization, an increase in the excitability of nociceptive neurons in the central nervous system that amplifies pain from within, so that after enough input a normally innocuous touch can hurt and a mildly noxious stimulus can hurt far more than it should (Woolf, 2011). Central sensitization is the mechanism by which a pain that began as cleanly nociceptive — the legible response of an intact system to real injury — can acquire the amplification that characterizes the harder chronic states, blurring the tidy boundary the taxonomy draws. It is the reason nociceptive pain is not simply a peripheral event: the same central machinery that gates the signal can also learn to magnify it.
Worked Example
Consider the single polymodal nociceptor the first demonstration computes, and use it to show why the pain a stimulus produces depends on the state of the receptor, not on the stimulus alone. Model the nociceptor's firing rate as a threshold-linear function of stimulus intensity: let the stimulus intensity be I on a zero-to-ten scale, the activation threshold be θ, and the gain be k, so the firing rate is F = max(0, k(I − θ)) impulses per second. A healthy nociceptor at rest has a high threshold — it should stay quiet for ordinary handling — say θ = 4 with a gain of k = 10.
Apply a mild stimulus, I = 3, the pressure of a firm touch. Because I is below threshold, F = max(0, 10 × (3 − 4)) = max(0, −10) = 0: the receptor is silent and nothing hurts, which is exactly what a healthy alarm should do with a non-damaging input. Now apply a genuinely noxious stimulus, I = 8: F = max(0, 10 × (8 − 4)) = 40 impulses per second, a strong signal, and the injury is felt as pain.
Now let the tissue become inflamed. The chemical mediators of injury sensitize the nociceptor, and peripheral sensitization does two things at once: it lowers the threshold and raises the gain, say to θ = 1 and k = 15. Reapply the same mild stimulus that was silent before, I = 3: now F = max(0, 15 × (3 − 1)) = 30 impulses per second. A touch that produced no signal at all in healthy tissue now drives the receptor nearly as hard as a real injury once did: the lowered threshold is the circuit-level basis of allodynia, pain from a normally innocuous stimulus, while the raised gain is the basis of hyperalgesia, an exaggerated response to a stimulus that was already painful. The stimulus never changed; the receptor did. This is why nociceptive pain, for all that its mechanism is the legible activation of nociceptors, is still not a fixed readout of the world: even at the very first synapse, what is transmitted is a function of the receptor's state, and every stage above it adds further modulation (Basbaum et al., 2009).
Discussion
The arc of nociceptive-pain research is the steady filling-in of a mechanism that older theories could only name. Specificity theory posited a dedicated pain line without a molecular basis; the discovery of the transducing channels supplied one, showing that noxious heat, cold, force, and chemistry are each detected by identifiable receptors on specialized fibers (Julius & Basbaum, 2001). Gate control theory posited that the signal is modulated on its way up; the physiology of the dorsal horn and of descending control supplied the circuitry, and central sensitization supplied the mechanism by which that modulation can run to amplification (Woolf, 2011). The mechanistic taxonomy then organized the whole field around the question that treatment actually turns on — by what route is this pain being generated — and made nociceptive pain the well-understood reference case against which neuropathic and nociplastic pain are defined (Treede et al., 2019).
The clinical stakes of getting the category right are large. Chronic pain imposes an enormous individual and societal burden, and mismatched treatment — an anti-inflammatory for a nociplastic pain, or the reverse — is both ineffective and, in the case of opioids for pain that will not respond to them, dangerous (Cohen et al., 2021). But the deepest lesson of the field is the one that keeps nociceptive pain within cognitive psychology at all: even here, in the mechanism where the tissue-damage link is real, pain is not the injury. It is what the brain makes of a modulated report about the injury, and the difference between the report and the experience is the space in which attention, expectation, and emotion do their work. The remainder of that story is the cognitive one.
Cognitive Implications
Because nociceptive pain is constructed rather than merely received, cognition is one of its determinants, and the clearest case is attention. Pain has an interruptive function: it is built to seize attention and pull it from whatever one was doing, which is what makes it useful as an alarm. Eccleston and Crombez modeled this as a cognitive-affective process in which pain, especially when novel, intense, or threatening, competes for the limited resources of selective attention, so a pain that is attended is amplified and a pain that is successfully ignored is diminished (Eccleston & Crombez, 1999). This is why distraction is a genuine if limited analgesic even for plainly nociceptive pain, and why anxiety, which locks attention on the threat, makes the same injury hurt more.
What determines whether attention can be redirected is itself shaped by appraisal. Pain catastrophizing — an exaggerated negative orientation toward actual or anticipated pain, marked by rumination, magnification, and helplessness — amplifies both the intensity and the disabling impact of nociceptive pain and is among the most robust psychological predictors of poor pain outcomes (Sullivan et al., 1995). These effects are not merely reported but built into the circuitry: the brain's cognitive and emotional control systems, acting through the same descending pathways gate control theory first proposed, physically set how much a nociceptive signal is amplified or suppressed before it is felt (Bushnell et al., 2013). Human neuroimaging traces this as a distributed and modifiable cerebral signature rather than a fixed pain center reading a tissue gauge (Apkarian et al., 2005). Taken together these findings are the mechanistic content of the biopsychosocial model, which holds that pain is always the joint product of biological, psychological, and social factors rather than a direct reading of nociception — a claim that applies with full force even to the category where nociception is doing exactly what it evolved to do (Gatchel et al., 2007).
Current Directions
Current research on nociceptive pain runs along two fronts, one molecular and one taxonomic. On the molecular side, the identification of the receptor channels that transduce noxious stimuli — recognized by the 2021 Nobel Prize in Physiology or Medicine — has opened a search for analgesics that act on nociceptors themselves rather than on the central nervous system, with the aim of relieving nociceptive pain without the sedation and dependence of opioids (Dubin & Patapoutian, 2010). Mapping the full complement of channels and mediators that set nociceptor sensitivity, and the neurotransmitter systems that carry and gate the signal centrally, remains an active program precisely because each element is a potential drug target (Yam et al., 2018).
On the taxonomic side, the introduction of nociplastic pain as a third mechanistic category has sharpened rather than settled the boundaries of nociceptive pain (Treede et al., 2019). The open questions are where a persistently amplified nociceptive pain, driven by central sensitization, stops being nociceptive and becomes nociplastic, and how to identify the mechanism at work in an individual patient when the categories overlap and coexist. Because mechanism is meant to guide treatment, resolving these boundaries is not a matter of nomenclature but of care, and it drives current work on the burden, best practices, and emerging treatments of chronic pain across all three categories (Cohen et al., 2021). The enduring lesson is the one the field began with: nociceptive pain is the response of an intact system to real injury, and understanding it means understanding not just the receptor but everything the nervous system does to its signal on the way to the felt experience.
Common Misconceptions
- Nociceptive pain is purely physical, with no psychological component.
- Even nociceptive pain is a constructed perception. Attention, expectation, and emotion modulate the signal through descending control and central sensitization, so the same injury can hurt very differently depending on psychological state (Bushnell et al., 2013).
- Nociceptive pain and nociception are the same thing.
- Nociception is the neural detection and transmission of noxious stimuli; nociceptive pain is the conscious experience the brain constructs from that input. Nociception can occur without pain, and the felt pain is a modulated product of the signal, not the signal itself (Melzack & Wall, 1965).
- A pain is either nociceptive or it is not.
- The mechanistic categories are descriptors, not exclusive diagnoses. A single patient can have nociceptive, neuropathic, and nociplastic mechanisms at once, and a long-standing nociceptive pain can acquire central amplification that pushes it toward the nociplastic (Treede et al., 2019).
Glossary
- Allodynia.
- Pain evoked by a stimulus that does not normally provoke pain, such as light touch on sunburned skin; a hallmark of peripheral or central sensitization.
- Central sensitization.
- An increase in the excitability of nociceptive neurons in the central nervous system that amplifies pain from within, so that pain can outrun or outlast the injury that started it.
- Descending modulation.
- Control of spinal pain transmission by pathways descending from the brain, the route through which attention, expectation, and emotion open or close the spinal gate.
- Gate control theory.
- Melzack and Wall's 1965 proposal that a spinal gate regulates nociceptive transmission to the brain according to the balance of large- and small-fiber input and descending control.
- Hyperalgesia.
- An increased pain response to a stimulus that is already painful; the exaggerated end of the sensitization that also produces allodynia.
- Mechanistic taxonomy.
- The classification of pain by its underlying mechanism — nociceptive, neuropathic, or nociplastic — rather than by its location, duration, or cause, adopted for ICD-11 because mechanism guides treatment.
- Neuromatrix.
- Melzack's proposal that the brain generates the felt body and its pains from a widely distributed network shaped by, but not dictated by, sensory input.
- Neuropathic pain.
- Pain caused by a lesion or disease of the somatosensory nervous system itself, as in diabetic neuropathy or nerve injury; contrasted with nociceptive pain.
- Nociception.
- The neural process by which noxious stimuli are detected, transduced, and transmitted toward the central nervous system; the physiological substrate of, but not identical to, pain.
- Nociceptive pain.
- Pain arising from actual or threatened damage to non-neural tissue through the activation of nociceptors, in a somatosensory system that is itself intact.
- Nociceptor.
- A primary afferent sensory neuron specialized, through its molecular receptor channels, to respond to stimuli that are or could become tissue-damaging.
- Nociplastic pain.
- Pain arising from altered nociception with no evident tissue damage activating nociceptors and no lesion of the somatosensory system, as in fibromyalgia; the third mechanistic category.
- Peripheral sensitization.
- A lowering of nociceptor threshold and raising of gain by the chemical mediators of inflammation, so that innocuous stimuli begin to signal as noxious.
- Polymodal nociceptor.
- A nociceptor carrying several receptor channels and so responding to more than one class of noxious stimulus — thermal, mechanical, and chemical — at once.
- Referred pain.
- Pain felt at a body-wall site distant from its true source, a consequence of visceral and somatic afferents converging on the same dorsal-horn neurons.
- Somatic pain.
- Nociceptive pain arising in the skin, muscles, joints, and bones, which are densely supplied with nociceptors and so localize it sharply.
- Transduction.
- The conversion of a noxious physical or chemical stimulus into an electrical signal by the receptor channels of a nociceptor; the first step of nociception.
- Visceral pain.
- Nociceptive pain originating in the internal organs, diffuse and poorly localized because visceral afferents are sparse and converge with somatic input in the spinal cord.
Key Researchers
David Julius (contemporary). Physiologist at the University of California, San Francisco whose identification of the capsaicin- and heat-gated channel TRPV1 opened the molecular study of nociception; co-recipient of the 2021 Nobel Prize in Physiology or Medicine. ORCID - Wikipedia - Wikidata
Ronald Melzack (1929-2019). McGill psychologist who, with Patrick Wall, originated the gate control theory of pain and later the neuromatrix theory, founding the modern psychology of pain. Wikipedia - Wikidata
Ardem Patapoutian (contemporary). Neuroscientist at Scripps Research and HHMI whose discovery of the Piezo mechanosensory ion channels illuminated how mechanical noxious stimuli are transduced; co-recipient of the 2021 Nobel Prize in Physiology or Medicine. ORCID - Wikipedia - Wikidata
Rolf-Detlef Treede (contemporary). Neurophysiologist at Heidelberg University who led the IASP Classification of Chronic Pain for ICD-11, formalizing the nociceptive, neuropathic, and nociplastic mechanistic descriptors. ORCID - Faculty page
Patrick D. Wall (1925-2001). Neuroscientist at University College London who, with Ronald Melzack, co-originated the gate control theory that reframed pain as a modifiable perception. Wikipedia - Wikidata
Clifford J. Woolf (contemporary). Neurobiologist at Harvard Medical School and Boston Children's Hospital who defined central sensitization and helped draw the modern taxonomy separating nociceptive from pathological pain. ORCID - Wikipedia - Wikidata
Frequently Asked Questions
What is nociceptive pain? Nociceptive pain is pain that arises from actual or threatened damage to non-neural tissue through the activation of nociceptors, the sensory receptors specialized for noxious stimuli. It is the pain of a working alarm system responding to injury in an otherwise intact nervous system, as with burns, fractures, or arthritis (Loeser & Treede, 2008).
How is nociceptive pain different from neuropathic and nociplastic pain? The three are mechanistic categories. Nociceptive pain comes from nociceptors detecting tissue damage; neuropathic pain comes from a lesion of the somatosensory nervous system itself; and nociplastic pain comes from altered nociception with no tissue damage and no nerve lesion. Mechanism, not location or duration, is what distinguishes them, because it guides treatment (Treede et al., 2019).
What is a nociceptor? A nociceptor is a primary afferent sensory neuron whose molecular receptor channels transduce noxious thermal, mechanical, and chemical stimuli into electrical signals. Most are polymodal, responding to more than one kind of noxious stimulus, and their discovery earned the 2021 Nobel Prize in Physiology or Medicine (Julius & Basbaum, 2001).
What is the difference between nociception and nociceptive pain? Nociception is the neural detection and transmission of noxious stimuli; nociceptive pain is the conscious experience the brain constructs from that input. The two usually occur together in nociceptive pain, but nociception can occur without pain, and the felt pain is a modulated product of the signal rather than the signal itself (Melzack & Wall, 1965).
What is the difference between somatic and visceral nociceptive pain? Somatic pain arises in skin, muscle, joints, and bone, tissues densely supplied with nociceptors, so it is sharp and well localized. Visceral pain arises in the internal organs, whose afferents are sparse and converge with somatic input in the spinal cord, so it is diffuse, hard to localize, and often referred to a distant body-wall site (Yam et al., 2018).
Can psychological factors really affect nociceptive pain? Yes. Even nociceptive pain is a constructed perception. Attention, catastrophizing, and emotion act through descending control and central sensitization to physically amplify or dampen the signal before it is felt, so the same injury can hurt very differently depending on psychological state (Bushnell et al., 2013; Eccleston & Crombez, 1999).
Why does inflamed tissue become so tender? The chemical mediators released by injured and inflamed tissue sensitize nociceptors, lowering their threshold and raising their gain. Stimuli that were innocuous now cross threshold and hurt, and stimuli that already hurt hurt more, the peripheral sensitization behind the tenderness of a wound (Basbaum et al., 2009).
Can nociceptive pain become chronic? It can. Sustained nociceptive input drives central sensitization, which amplifies pain from within the nervous system, and a long-standing nociceptive pain can acquire the amplification that characterizes harder chronic states. Chronic pain imposes a large burden and is a central concern of current pain research (Woolf, 2011; Cohen et al., 2021).
References
Apkarian, A. V., Bushnell, M. C., Treede, R.-D., & Zubieta, J.-K. (2005). Human brain mechanisms of pain perception and regulation in health and disease. European Journal of Pain, 9(4), 463-484. https://doi.org/10.1016/j.ejpain.2004.11.001
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009). Cellular and molecular mechanisms of pain. Cell, 139(2), 267-284. https://doi.org/10.1016/j.cell.2009.09.028
Bushnell, M. C., Čeko, M., & Low, L. A. (2013). Cognitive and emotional control of pain and its disruption in chronic pain. Nature Reviews Neuroscience, 14(7), 502-511. https://doi.org/10.1038/nrn3516
Cohen, S. P., Vase, L., & Hooten, W. M. (2021). Chronic pain: An update on burden, best practices, and new advances. The Lancet, 397(10289), 2082-2097. https://doi.org/10.1016/S0140-6736(21)00393-7
Dubin, A. E., & Patapoutian, A. (2010). Nociceptors: The sensors of the pain pathway. The Journal of Clinical Investigation, 120(11), 3760-3772. https://doi.org/10.1172/JCI42843
Eccleston, C., & Crombez, G. (1999). Pain demands attention: A cognitive-affective model of the interruptive function of pain. Psychological Bulletin, 125(3), 356-366. https://doi.org/10.1037/0033-2909.125.3.356
Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N., & Turk, D. C. (2007). The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychological Bulletin, 133(4), 581-624. https://doi.org/10.1037/0033-2909.133.4.581
Julius, D., & Basbaum, A. I. (2001). Molecular mechanisms of nociception. Nature, 413(6852), 203-210. https://doi.org/10.1038/35093019
Loeser, J. D., & Treede, R.-D. (2008). The Kyoto protocol of IASP Basic Pain Terminology. Pain, 137(3), 473-477. https://doi.org/10.1016/j.pain.2008.04.025
Melzack, R. (1999). From the gate to the neuromatrix. Pain, 82(Suppl 6), S121-S126. https://doi.org/10.1016/S0304-3959(99)00145-1
Melzack, R., & Wall, P. D. (1965). Pain mechanisms: A new theory. Science, 150(3699), 971-979. https://doi.org/10.1126/science.150.3699.971
Raja, S. N., Carr, D. B., Cohen, M., Finnerup, N. B., Flor, H., Gibson, S., Keefe, F. J., Mogil, J. S., Ringkamp, M., Sluka, K. A., Song, X.-J., Stevens, B., Sullivan, M. D., Tutelman, P. R., Ushida, T., & Vader, K. (2020). The revised International Association for the Study of Pain definition of pain: Concepts, challenges, and compromises. Pain, 161(9), 1976-1982. https://doi.org/10.1097/j.pain.0000000000001939
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The Pain Catastrophizing Scale: Development and validation. Psychological Assessment, 7(4), 524-532. https://doi.org/10.1037/1040-3590.7.4.524
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., Giamberardino, M. A., Kaasa, S., Korwisi, B., Kosek, E., Lavand'homme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., ... Wang, S.-J. (2019). Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain, 160(1), 19-27. https://doi.org/10.1097/j.pain.0000000000001384
Woolf, C. J. (2010). What is this thing called pain? The Journal of Clinical Investigation, 120(11), 3742-3744. https://doi.org/10.1172/JCI45178
Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3 Suppl), S2-S15. https://doi.org/10.1016/j.pain.2010.09.030
Yam, M. F., Loh, Y. C., Tan, C. S., Khadijah Adam, S., Abdul Manan, N., & Basir, R. (2018). General pathways of pain sensation and the major neurotransmitters involved in pain regulation. International Journal of Molecular Sciences, 19(8), 2164. https://doi.org/10.3390/ijms19082164